Press Release
The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook
Broad strength despite logistics and pandemic related headwinds – full year 2022 outlook targets continued earnings growth and strong free cash flow generation The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announces it...
Read More
Press Release
Chemours Announces First Quarter Dividend
The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the first quarter of 2022.
Read More
News Article
Chemours' CEO Mark Newman Awarded "Culture Builder of the Year" in Technical.ly Awards - Delaware
The award recognizes empathetic leaders who are making their workplace, professional group, or broader community more inclusive, resilient, or engaging.
Read More
Press Release
Chemours Completes Sale of Mining Solutions Business to Draslovka for $521 Million
The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced it completed the sale of its Mining Solutions business to Draslovka Holding a.s.
Read More
News Article
Chemours Applauds the Biden Administration’s Support for Ratifying the Kigali Amendment to the Montreal Protocol
On the heels of COP26 and with the first step in the phase down of hydrofluorocarbons (HFCs) under the U.S. American Innovation and Manufacturing (AIM) Act set to go into effect January 1, 2022, Chemours applauds the Biden administration’s support for ratifying the Kigali Amendment to the Montreal Protocol and encourages the Senate to swiftly ratify the treaty.
Read More
Press Release
Chemours Adds Glyclean™ D to Its World-Class Glycolic Acid Product Portfolio
U.S. EPA approved, Glyclean™ D uses the power of nature to effectively and efficiently kill viruses and bacteria The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the launch of Glyclean™ D —a proven broad spectr...
Read More